HNMPA-(AM)3 ≥98% (by TLC)

Supplier: Enzo Life Sciences

Synonyms: Hydroxy-2-naphthalenylmethylphosphonic acid tri-acetoxymethyl ester

BML-EI248-0005 BML-EI248-0025
89157-866EA 183.87 USD
89157-866 89157-868
HNMPA-(AM)3 ≥98% (by TLC)
HNMPA-(AM)3

HNMPA-(AM)3 is a cell-permeable analog of HNMPA. It inhibits insulin receptor tyrosine kinase activity (IC50=100 µM) and insulin-stimulated glucose oxidation in isolated rat adipocytes (IC50=10 µM). It has no effect on PKA (at concs. up to 1 mM) or PKC (at concs. up to 420 µM). Inhibits both serine and tyrosine autophosphorylation by the human insulin receptor. Does not affect protein kinase C (PKC) or cAMP-dependent protein kinase (PKA).


  • Insulin receptor inhibitor


Colorless oil.


Soluble in DMSO (>20mg/ml) or 100% ethanol (>20mg/ml).

Formula: C₂₀H₂₃O₁₀P
MW: 454.4 g/mol
Storage Temperature: Freezer
CAS Number: 120944-03-8
https://us.vwr.com/stibo/web/std.lang.all/37/12/45403712.jpg

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR